Boston Scientific Showcases One of the Largest Rooftop Solar Power Installations in Massachusetts
Earth Week Celebration Focuses on 3,900-Panel Project at the Company’s International Distribution Center in Quincy

Natick, Mass. (April 24, 2013)—Boston Scientific Corporation (NYSE:BSX) celebrates Earth Week by inaugurating a 3,900-panel rooftop solar installation atop the company’s international distribution center in Quincy, Massachusetts.  Today’s event showcases the company’s commitment to supporting renewable energy and sustainability initiatives.

“Boston Scientific is proud to be the host of one of the largest rooftop solar installations in Massachusetts,” said Ken Pucel, executive vice president, Global Operations, Quality and Technology, Boston Scientific.  “We support efforts to enhance environmental performance and integrate environmental sustainability into our processes.  This project is one of the many ways we show our commitment to sustainable principles across the organization.”

The 1.28-megawatt solar energy system generates an average of 1,685,000 kilowatt-hours a year, or enough electricity to serve 145 average-sized American homes a year.  The installation covers 120,000 square feet on a roof that is 850,000 square feet in size and powers approximately 25 percent of the Boston Scientific international distribution center.  This is the third-largest rooftop solar installation in Massachusetts, according to data provided by the Massachusetts Executive Office of Energy and Environmental Affairs.

The project was developed by HelioSage Energy, a national developer of large-scale solar projects, in collaboration with Consolidated Edison Solutions, Inc. (ConEdison Solutions), a leading energy services company and a subsidiary of Consolidated Edison, Inc.  ConEdison Solutions serves as project owner/operator and sells the electricity produced by the system to Boston Scientific through a 20-year Power Purchase Agreement.

“ConEdison Solutions is proud to work with Boston Scientific, one of the world’s outstanding leaders in the medical device industry,” said Michael W. Gibson, vice president, Energy Services, ConEdison Solutions.  “Boston Scientific deserves praise for its leadership.  We appreciate its visionary approach to sustainability.”

“Thanks to the leadership of companies like Boston Scientific, Massachusetts is a national clean energy leader,” said Rick Sullivan, secretary, Executive Office of Energy and Environmental Affairs.  “Boston Scientific – working in cooperation with ConEdison Solutions and HelioSage – tapped state incentives that promote investment in renewable energy sources.  With the vigorous encouragement of the Patrick-Murray Administration, these incentives are playing a key role in affirming Massachusetts’ status as a solar leader.  We encourage the private sector to follow Boston Scientific’s lead and help expand Massachusetts’ embrace of clean and renewable power.”

Underscoring the international commitment by Boston Scientific to environmental sustainability, the Quincy complex is one of 13 sites worldwide certified under the globally recognized ISO14001 standard for environmental management systems, as established by the International Standards Organization.  Boston Scientific has also been certified in the "FTSE4Good" Corporate Social Responsibility Index fund since 2004.  Managed by the London Stock Exchange Group, the stock index measures the performance of companies that meet globally recognized standards of corporate responsibility.

Local students, who are part of the Quincy community’s High School Electricians Core Competency Program, attended an educational seminar on solar power electrical generation to prepare for the event and participate in the celebration.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit and connect on Twitter and Facebook.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding our business plans and environmental sustainability efforts.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.

Steven Campanini
508-652-5740 (office)
Global Media Relations
Boston Scientific Corporation

Michael Campbell
508-650-8023 (office)
Investor Relations
Boston Scientific Corporation